Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, Burstein R. Global burden of disease attributable to mental and substance use disorders: findings from the global burden of Disease Study 2010. Lancet. 2013;382(9904):1575–86.
Squeglia LM, Jacobus J, Tapert SF. The influence of substance use on adolescent brain development. Clin EEG Neurosci. 2009;40(1):31–8.
Article CAS PubMed PubMed Central Google Scholar
Hall WD, Patton G, Stockings E, Weier M, Lynskey M, Morley KI, Degenhardt L. Why young people’s substance use matters for global health. Lancet Psychiatry. 2016;3(3):265–79.
Lamps CA, Sood AB, Sood R. Youth with substance abuse and comorbid mental health disorders. Curr Psychiatry Rep. 2008;10(3):265–71.
Hamidullah S, Thorpe HH, Frie JA, Mccurdy RD, Khokhar JY. Adolescent substance use and the brain: behavioral, cognitive and neuroimaging correlates. Front Hum Neurosci. 2020;14:517606.
Gomes ST, Frota MV, Aguiar MB, Nogueira MB. Substance abuse and depression in adolescents. Neuropsychiatrie De l’Enfance et de l’Adolescence. 2012;5(60):S243.
Quinn K, Walsh JL, Dickson-Gomez J. Multiple marginality and the variation in delinquency and substance use among adolescent gang members. Subst Use Misuse. 2019;54(4):612–27.
Chambers RA, Taylor JR, Potenza MN. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. Am J Psychiatry. 2003;160(6):1041–52.
Article PubMed PubMed Central Google Scholar
Jordan CJ, Andersen SL. Sensitive periods of substance abuse: early risk for the transition to dependence. Dev Cogn Neurosci. 2017;25:29–44.
Halladay J, Woock R, El-Khechen H, Munn C, MacKillop J, Amlung M, Ogrodnik M, Favotto L, Aryal K, Noori A, Kiflen M. Patterns of substance use among adolescents: a systematic review. Drug Alcohol Depend. 2020;216:108222.
Article CAS PubMed Google Scholar
Blanco C, Flórez-Salamanca L, Secades‐Villa R, Wang S, Hasin DS. Predictors of initiation of nicotine, alcohol, cannabis, and cocaine use: results of the national epidemiologic survey on Alcohol and related conditions (NESARC). Am J Addictions. 2018;27(6):477–84.
Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2005 national survey on drug use and health: national findings. 2006.
Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC, Angermeyer M, Bruffaerts R, De Girolamo G, Gureje O, Huang Y, Karam A. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008;5(7):e141.
Article PubMed PubMed Central Google Scholar
Stockings E, Hall WD, Lynskey M, Morley KI, Reavley N, Strang J, Patton G, Degenhardt L. Prevention, early intervention, harm reduction, and treatment of substance use in young people. Lancet Psychiatry. 2016;3(3):280–96.
Swift W, Coffey C, Carlin JB, Degenhardt L, Patton GC. Adolescent cannabis users at 24 years: trajectories to regular weekly use and dependence in young adulthood. Addiction. 2008;103(8):1361–70.
Degenhardt L, Ferrari AJ, Calabria B, Hall WD, Norman RE, McGrath J, Flaxman AD, Engell RE, Freedman GD, Whiteford HA, Vos T. The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLoS ONE. 2013;8(10):e76635.
Article CAS PubMed PubMed Central Google Scholar
Degenhardt L, Baxter AJ, Lee YY, Hall W, Sara GE, Johns N, Flaxman A, Whiteford HA, Vos T. The global epidemiology and burden of psychostimulant dependence: findings from the global burden of Disease Study 2010. Drug Alcohol Depend. 2014;137:36–47.
Degenhardt L, Charlson F, Mathers B, Hall WD, Flaxman AD, Johns N, Vos T. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction. 2014;109(8):1320–33.
Degenhardt L, Stockings E, Patton G, Hall WD, Lynskey M. The increasing global health priority of substance use in young people. Lancet Psychiatry. 2016;3(3):251–64.
Hawkins EH. A tale of two systems: co-occurring mental health and substance abuse disorders treatment for adolescents. Ann Rev Psychol. 2009;60:197–227.
Hadland SE, Yule AM, Levy SJ, Hallett E, Silverstein M, Bagley SM. Evidence-based treatment of young adults with substance use disorders. Pediatrics. 2021;147(Supplement 2):S204–14.
Volkow ND, Han B, Einstein EB, Compton WM. Prevalence of substance use disorders by time since first substance use among young people in the US. JAMA Pediatr. 2021;175(6):640–3.
Article PubMed PubMed Central Google Scholar
WHO-ASSIST Working Group. The alcohol, smoking and substance involvement screening test (ASSIST): development, reliability and feasibility. Addiction. 2002;97(9):1183–94.
Humeniuk R, Ali R, Babor TF, Farrell M, Formigoni ML, Jittiwutikarn J, De Lacerda RB, Ling W, Marsden J, Monteiro M, Nhiwatiwa S. Validation of the alcohol, smoking and substance involvement screening test (ASSIST). Addiction. 2008;103(6):1039–47.
Humeniuk R, Holmwood C, Beshara M, Kambala A. ASSIST-Y v1. 0: first-stage development of the who alcohol, smoking and substance involvement screening test (assist) and linked brief intervention for young people. J Child Adolesc Subst Abuse. 2016;25(4):384–90.
Källmén H, Berman AH, Jayaram-Lindström N, Hammarberg A, Elgán TH. Psychometric properties of the AUDIT, AUDIT-C, CRAFFT and ASSIST-Y among Swedish adolescents. Eur Addict Res. 2019;25(2):68–77.
World Health Organization. Process of translation and adaptation of instruments. http://www.who.int/substance_abuse/research_tools/translation/en/.2009
Legleye S, Karila L, Beck F, Reynaud M. Validation of the CAST, a general population Cannabis abuse screening test. J Subst use. 2007;12(4):233–42.
Rial A, García-Couceiro N, Gómez P, Mallah N, Varela J, Flórez-Menéndez G, Isorna M. Psychometric properties of CAST for early detection of problematic cannabis use in Spanish adolescents. Addict Behav. 2022;129:107288.
Fernandez-Artamendi S, Fernández-Hermida JR, Muñiz-Fernández J, Secades-Villa R, García-Fernández G. Screening of cannabis-related problems among youth: the CPQ-AS and CAST questionnaires. Subst Abuse Treat Prev Policy. 2012;7(1):1–0.
Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90(5):607–14.
Article CAS PubMed Google Scholar
Lawrinson P, Copeland J, Gerber S, Gilmour S. Determining a cut-off on the severity of dependence scale (SDS) for alcohol dependence. Addict Behav. 2007;32(7):1474–9.
Cuevas CD, Sanz EJ, Fuente JA, Padilla J, Berenguer JC. The severity of dependence scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction. 2000;95(2):245–50.
Vélez-Moreno A, González-Saiz F, Rojas AJ, Torrico-Linares E, Fernández-Calderón F, Ramírez-López J, Lozano OM. Reliability and validity of the Spanish version of the substance dependence severity scale. Eur Addict Res. 2014;21(1):39–46.
Knight JR, Shrier LA, Bravender TD, Farrell M, Vander Bilt J, Shaffer HJ. A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med. 1999;153(6):591–6.
Article CAS PubMed Google Scholar
Rial A, Kim-Harris S, Knight JR, Araujo M, Gómez P, Braña T, Varela J, Golpe S. Empirical validation of the CRAFFT abuse screening test in a Spanish sample. Validación empírica del CRAFFT abuse screening. Test en una muestra de adolescentes españoles. Adicciones. 2019;31:160–9.
留言 (0)